Neurotech International Limited (NTI.AX)
AUD 0.03
(-3.57%)
AUD 0.03
(-3.57%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -5.06 Million AUD | 34.94% |
| 2023 | -7.79 Million AUD | -131.75% |
| 2022 | -3.36 Million AUD | 54.75% |
| 2021 | -7.43 Million AUD | -333.67% |
| 2020 | -1.71 Million AUD | 64.32% |
| 2019 | -4.8 Million AUD | -20.35% |
| 2018 | -3.99 Million AUD | 1.03% |
| 2017 | -4.03 Million AUD | -84.83% |
| 2016 | -2.18 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -4.34 Million AUD | 0.0% |
| 2024 Q2 | -728.77 Thousand AUD | 0.0% |
| 2024 FY | -5.06 Million AUD | 34.94% |
| 2023 FY | -7.79 Million AUD | -131.75% |
| 2023 Q2 | -3.53 Million AUD | 0.0% |
| 2023 Q4 | -4.25 Million AUD | 0.0% |
| 2022 Q2 | -1.81 Million AUD | 0.0% |
| 2022 FY | -3.36 Million AUD | 54.75% |
| 2022 Q4 | -1.54 Million AUD | 0.0% |
| 2021 FY | -7.43 Million AUD | -333.67% |
| 2021 Q4 | -3.8 Million AUD | 0.0% |
| 2021 Q2 | -3.62 Million AUD | 0.0% |
| 2020 Q4 | -950.11 Thousand AUD | 0.0% |
| 2020 FY | -1.71 Million AUD | 64.32% |
| 2020 Q2 | -763.32 Thousand AUD | 0.0% |
| 2019 Q2 | -1.78 Million AUD | 0.0% |
| 2019 Q4 | -3.02 Million AUD | 0.0% |
| 2019 FY | -4.8 Million AUD | -20.35% |
| 2018 Q4 | -2.05 Million AUD | 0.0% |
| 2018 FY | -3.99 Million AUD | 1.03% |
| 2018 Q2 | -1.93 Million AUD | 0.0% |
| 2017 Q4 | -1.92 Million AUD | 0.0% |
| 2017 Q2 | -2.1 Million AUD | 0.0% |
| 2017 FY | -4.03 Million AUD | -84.83% |
| 2016 Q2 | -611.17 Thousand AUD | -100.0% |
| 2016 Q1 | -305.58 Thousand AUD | 0.0% |
| 2016 Q3 | - AUD | 100.0% |
| 2016 FY | -2.18 Million AUD | 0.0% |
| 2016 Q4 | -2.18 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 85.91% |
| Adherium Limited | -10.22 Million AUD | 50.419% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 47.998% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 25.973% |
| Anteris Technologies Ltd | -67.33 Million AUD | 92.471% |
| Control Bionics Limited | -5.91 Million AUD | 14.281% |
| CardieX Limited | -6.76 Million AUD | 25.071% |
| Compumedics Limited | -338 Thousand AUD | -1399.778% |
| Cochlear Limited | 356.8 Million AUD | 101.421% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -62.105% |
| Cyclopharm Limited | -4.7 Million AUD | -7.838% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -85.713% |
| Nova Eye Medical Limited | -8.79 Million AUD | 42.329% |
| HeraMED Limited | -6.78 Million AUD | 25.273% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 77.595% |
| ImpediMed Limited | -19.79 Million AUD | 74.385% |
| InhaleRx Limited | -1.44 Million AUD | -251.233% |
| LBT Innovations Limited | -3.74 Million AUD | -35.541% |
| Micro-X Limited | -9.76 Million AUD | 48.088% |
| OncoSil Medical Limited | -11.91 Million AUD | 57.45% |
| PolyNovo Limited | 5.26 Million AUD | 196.355% |
| Respiri Limited | -7.12 Million AUD | 28.895% |
| SomnoMed Limited | -12.24 Million AUD | 58.59% |
| Universal Biosensors, Inc. | -6.74 Million AUD | 24.806% |
| Uscom Limited | -2.07 Million AUD | -144.331% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -0.117% |